ADCETRIS: payments to doctors
Payments that named ADCETRIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $10.8M
- Providers
- 11,706
- Transactions
- 54,350
- Average per transaction
- $199
The per-transaction average — $199 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,706 providers the average total is $925, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Seagen Inc. | $7,486,160 | 69.1% |
| Pfizer | $1,730,591 | 16.0% |
| Seattle Genetics, Inc. | $1,514,687 | 14.0% |
| Takeda Pharmaceuticals U.S.A., Inc. | $85,440 | 0.8% |
| PBG Puerto RICO LLC | $6,551 | 0.1% |
| Takeda Pharmaceutical Company, Limited | $3,300 | 0.0% |
| Array Biopharma Inc | $456 | 0.0% |